Humoral immunity of BBIBP‐CorV (Sinopharm) in kidney transplant recipients: Is it time to revise vaccination strategies
Sign Up to like & getrecommendations! Published in 2022 at "Transplant Infectious Disease"
DOI: 10.1111/tid.13798
Abstract: The mortality of coronavirus disease 2019 (COVID‐19) is high in transplant patients, and effective vaccination is aimed to reduce severe disease and mortality. read more here.
Keywords: immunity bbibp; corv sinopharm; vaccination; bbibp corv ... See more keywords